The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world evidence of survival in locally advanced esophago-gastric cancers treated with perioperative chemotherapy vs preoperative chemoradiotherapy.
 
Mosunmoluwa Oyenuga
No Relationships to Disclose
 
Subir Goyal
No Relationships to Disclose
 
Oluwadunni Emiloju
Stock and Other Ownership Interests - Telix Pharmaceuticals
 
Lindsay Hannan
No Relationships to Disclose
 
Ruoyu Miao
No Relationships to Disclose
 
Olumide Gbolahan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boston Scientific; Cardinal Health; Curio Science; Incyte; Lantheus Medical Imaging; Merus
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Eisai (Inst); Elicio Therapeutics (Inst); EMD Serono (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Relay Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Maria Russell
No Relationships to Disclose
 
Jeffrey Switchenko
No Relationships to Disclose
 
Olatunji Alese
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; Exelixis; GlaxoSmithKline; Ipsen; Loxo/Lilly; Taiho Oncology; Takeda
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - COMPASS THERAPEUTICS, INC